IMMUNE-MEDIATED PNEUMONITIS

This adverse event was reported 234 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED PNEUMONITIS:

# Drug Count
0 NIVOLUMAB 71
1 CARBOPLATIN 35
2 IPILIMUMAB 33
3 PEMETREXED DISODIUM 29
4 DURVALUMAB 19
5 METHYLPREDNISOLONE 10
6 PACLITAXEL 10
7 INFLIXIMAB 9
8 ONDANSETRON 7
9 ONDANSETRON HYDROCHLORIDE 7
See all common drugs associated with IMMUNE-MEDIATED PNEUMONITIS

IMMUNE-MEDIATED PNEUMONITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 3 0.0056
1 NALDEMEDINE 2 0.0012
2 DUVELISIB 1 0.0012
3 DURVALUMAB 19 0.0009
4 IPILIMUMAB 33 0.0008
5 PEMETREXED DISODIUM 29 0.0007
6 NIVOLUMAB 71 0.0007
7 ANIDULAFUNGIN 1 0.0006
8 IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE 1 0.0006
9 MITOTANE 1 0.0005
See all drugs enriched for association with IMMUNE-MEDIATED PNEUMONITIS